UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

Frontiers in oncology, 2021-07, Vol.11, p.693104-693104

2021

Volltextzugriff (PDF)

Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells

Investigational new drugs, 2012-08, Vol.30 (4), p.1279-1288

2012

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker

Biomarker Insights, 2022-02, Vol.17, p.11772719221078774-11772719221078774

2022

Volltextzugriff (PDF)

Association of Body Mass Index, Central Obesity, and Body Composition With Mortality Among Black Breast Cancer Survivors

JAMA oncology, 2021-08, Vol.7 (8), p.1186

2021

Volltextzugriff (PDF)

Abstract 5247: Caffeic acid phenethyl ester (CAPE) reverses aggressive breast cancer in the radiation chimera model

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5247-5247

2016

Volltextzugriff (PDF)

Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis

JCO global oncology, 2021-12, Vol.7 (7), p.289-301

2021

Volltextzugriff (PDF)

Neighborhood Archetypes and Cardiovascular Health in Black Breast Cancer Survivors

JACC CardioOncology, 2024-06, Vol.6 (3), p.405-418

2024

Volltextzugriff (PDF)

Greater Body Fatness Is Associated With Higher Protein Expression of LEPR in Breast Tumor Tissues: A Cross-Sectional Analysis in the Women’s Circle of Health Study

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.879164-879164

2022

Volltextzugriff (PDF)

The Present and Future of Postmastectomy Radiation

International journal of radiation oncology, biology, physics, 2024-02, Vol.118 (2), p.466-467

2024

Volltextzugriff (PDF)

Predicting response to neoadjuvant therapy (NAT) in patients (pts) with early-stage breast cancer (BC) using circulating tumor DNA (ctDNA) testing

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.569-569

2024

Volltextzugriff (PDF)

Psychiatric and affective predictors of negative racial attitudes

Psychiatry research, 2023-09, Vol.327, p.115376-115376, Article 115376

2023

Volltextzugriff (PDF)

Abstract OT2-25-01: Irene study: Phase 2 study of Incmga00012 and the oncolytic virus pelareorep in metastatic triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-25-01-OT2-25-01

2022

Volltextzugriff (PDF)

Breast cancer receptor subtypes in East Africa: A systematic review and meta-analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19074-e19074

2020

Volltextzugriff (PDF)

Anti-VEGF therapy - a role in obesity-related breast cancer

Nature reviews. Endocrinology, 2018-06, Vol.14 (6), p.329-330

2018

Volltextzugriff (PDF)

Abstract PO-119: Association of body mass index with pathological complete response after neoadjuvant chemotherapy in a population-based cohort of Black breast cancer patients

Cancer epidemiology, biomarkers & prevention, 2022-01, Vol.31 (1_Supplement), p.PO-119-PO-119

2022

Volltextzugriff (PDF)

Abstract PO-205: Association of pre-diagnostic cigarette smoking and alcohol consumption with mortality in Black breast cancer survivors

Cancer epidemiology, biomarkers & prevention, 2022-01, Vol.31 (1_Supplement), p.PO-205-PO-205

2022

Volltextzugriff (PDF)

Abstract P2-12-15: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of early stage triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-12-15

2022

Volltextzugriff (PDF)

Abstract OT1-17-02: A phase II study of pembrolizumab plus fulvestrant in hormone receptor positive, HER-2 negative advanced/metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-17-02-OT1-17-02

2022

Volltextzugriff (PDF)

Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA612-LBA612

2023

Volltextzugriff (PDF)

Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA520-LBA520

2023

Volltextzugriff (PDF)

Abstract OT-32-02: Irene study: Phase 2 study of incmga00012 (retifanlimab)and the oncolytic virus pelareorep in metastatic triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-32-02-OT-32-02

2021

Volltextzugriff (PDF)

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature medicine, 2024-09

2024

Volltextzugriff (PDF)

Abstract PO4-22-04: Evaluation of acute toxicity in breast cancer patients receiving concurrent capecitabine and radiation

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-22-04-PO4-22-04

2024

Volltextzugriff (PDF)

Pre-diagnostic allostatic load as a predictor of poorly differentiated and larger sized breast cancers among Black women in the Women’s Circle of Health Follow-Up Study

Cancer epidemiology, biomarkers & prevention, 2019-11, Vol.29 (1), p.216-224

2019

Volltextzugriff (PDF)

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature medicine, 2024-09

2024

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(41)
Dissertationen
(1)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker

Association of Body Mass Index, Central Obesity, and Body Composition With Mortality Among Black Breast Cancer Survivors

Abstract 5247: Caffeic acid phenethyl ester (CAPE) reverses aggressive breast cancer in the radiation chimera model

Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis

Neighborhood Archetypes and Cardiovascular Health in Black Breast Cancer Survivors

Greater Body Fatness Is Associated With Higher Protein Expression of LEPR in Breast Tumor Tissues: A Cross-Sectional Analysis in the Women’s Circle of Health Study

The Present and Future of Postmastectomy Radiation

Predicting response to neoadjuvant therapy (NAT) in patients (pts) with early-stage breast cancer (BC) using circulating tumor DNA (ctDNA) testing

Psychiatric and affective predictors of negative racial attitudes

Abstract OT2-25-01: Irene study: Phase 2 study of Incmga00012 and the oncolytic virus pelareorep in metastatic triple negative breast cancer

Breast cancer receptor subtypes in East Africa: A systematic review and meta-analysis

Anti-VEGF therapy - a role in obesity-related breast cancer

Abstract PO-119: Association of body mass index with pathological complete response after neoadjuvant chemotherapy in a population-based cohort of Black breast cancer patients

Abstract PO-205: Association of pre-diagnostic cigarette smoking and alcohol consumption with mortality in Black breast cancer survivors

Abstract P2-12-15: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of early stage triple negative breast cancer

Abstract OT1-17-02: A phase II study of pembrolizumab plus fulvestrant in hormone receptor positive, HER-2 negative advanced/metastatic breast cancer patients

Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL

Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL

Abstract OT-32-02: Irene study: Phase 2 study of incmga00012 (retifanlimab)and the oncolytic virus pelareorep in metastatic triple negative breast cancer

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Abstract PO4-22-04: Evaluation of acute toxicity in breast cancer patients receiving concurrent capecitabine and radiation

Pre-diagnostic allostatic load as a predictor of poorly differentiated and larger sized breast cancers among Black women in the Women’s Circle of Health Follow-Up Study

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Aktive Filter

Suchergebnisse filtern